True to form, ASHP took the high road on several issues during a press conference at its midyear meeting in Orlando last month.
SGLT2 Inhibitors May Have Clinical Benefits For Patients with Diabetes After Myocardial Infarction | ASHP Midyear
Research found that SGLT2 inhibitors were associated with a lower risk of major cardiovascular events or hospitalization for heart failure.
Reach Your Business Goals in 2021
In part 1 of our podcast series with American Associated Pharmacies (AAP), AAP President and CEO Jon Copeland dives into key pharmacy industry trends.
In A Warming World, Climate-Resilient Health Care Delivery Is Key | ASHP Midyear
Pharmacists can influence institutional-level climate change-related policies to ensure continued health care delivery.
ThoughtSpot Series: Closing the Healthcare Gap
Our final episode in our ThoughtSpot 2020 podcast series features NPhA president Dr. Ryan Marable and immediate past president Dr. Lakesha Butler, who share insights on health disparities and the social determinants of health.
DES Model Successfully Simulated MASH Diagnosis | ASHP Midyear
Researchers observed the use of a discrete event simulation using non-invasive tests for patients with nonalcoholic steatohepatitis.
Assessing Improvements to Reduce Insulin-Related Hypoglycemic Events | ASHP Midyear
Medication alerts, nurse education, and pharmacist interventions led to lower hypoglycemic events every year after they were implemented.